Concepedia

Per Andersson

PA

Statistics

Publications

2

Citations

24

H-Index

2

Active since

2023

Affiliations

Uppsala University(Current)

Per Andersson is an author at Uppsala University specializing in solid dispersion formulation, pharmacokinetic enhancement, and pharmacokinetics.

Publications per year

2023–2024

2

Publications

2

Despite warnings, co‐medication with proton pump inhibitors and dasatinib is common in chronic myeloid leukemia, but <scp>XS004</scp>, a novel oral dasatinib formulation, provides reduced <scp>pH‐dependence</scp>, minimizing undesirable <scp>drug–drug</scp> interactions

Gunnar Larfors, Per Andersson, Gérald Jesson et al. · European Journal Of Haematology · 2023 · 12 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +13

Enhanced Bioavailability and Reduced Variability of Dasatinib and Sorafenib with a Novel Amorphous Solid Dispersion Technology Platform

Hans Lennernäs, Magnus Brisander, Charlotta Liljebris et al. · Clinical Pharmacology in Drug Development · 2024 · 12 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–2 of 2